Modulation of nitric oxide production by lung surfactant in alveolar macrophages.
Kalina
M
M
Department of Cell Biology and Histology, Sackler School of Medicine, Tel-Aviv University, Israel.
Blau
H
H
Riklis
S
S
Hoffman
V
V
D000818:Animals; D002460:Cell Line; D004338:Drug Combinations; D004926:Escherichia coli; D005233:Fatty Alcohols / Q000494:pharmacology; D006023:Glycoproteins / Q000494:pharmacology*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000502:physiology*; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II; D009573:Nitrites / Q000378:metabolism; D010743:Phospholipids / Q000494:pharmacology*; D010767:Phosphorylcholine; D011092:Polyethylene Glycols / Q000494:pharmacology; D011510:Proteolipids / Q000494:pharmacology*; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins; D019323:omega-N-Methylarginine / Q000494:pharmacology
D004338:Drug Combinations; D005233:Fatty Alcohols; D006023:Glycoproteins; D008070:Lipopolysaccharides; D009573:Nitrites; D010743:Phospholipids; D011510:Proteolipids; D037663:Pulmonary Surfactant-Associated Protein D; D037661:Pulmonary Surfactant-Associated Proteins; D011663:Pulmonary Surfactants; D011994:Recombinant Proteins; D010767:Phosphorylcholine; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D011092:Polyethylene Glycols; D007371:Interferon-gamma; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat